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Abstract
Purpose: Caseous calcification is a relatively uncommon variant of calcification of the mitral annulus. The purpose 
of the study was to assess characteristic radiological features of caseous calcification of the mitral annulus (CCMA) 
using computed tomography (CT) and compare the usefulness of CT and transthoracic echocardiogram (TTE) in 
a diagnosis of CCMA.
Material and methods: Seventeen patients with CCMA, who underwent TTE and CT, were analysed. The following fea-
tures of CCMA were evaluated: location, size, attenuation, enhancement after contrast administration, and margins.
Results: In all cases TTE visualised an echo-dense structure with an irregular appearance involving the mitral valve 
annulus. In five cases the acoustic shadowing artefact was visible, and in four cases the mass contained central areas 
of echolucency. Eleven patients had valve disease.
On CT CCMA appeared as a round mass in one case, in 10 cases as an oval mass, and in six patients it had a sem-
ilunar shape.
In all cases on unenhanced CT, CCMA appeared as a hyperdense mass. On enhanced CT, CCMA in 10 cases (58.8%) 
had a hypodense centre, and in 7seven (41.2%) it had a hyperdense centre without enhancement after contrast ad-
ministration. A hyperdense rim was observed in all cases except one patient.
Conclusions: In cases of the atypical appearance of CCMA on TTE, CT can lead to a definitive diagnosis. The combi-
nation of unenhanced CT and after IV contrast administration scans allows for recognition and distinction of CCMA 
from other pathologies, while TTE allows for assessment of additional valve dysfunction.
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Introduction
Calcification of the mitral annulus (MAC) is a chronic, 
degenerative process, which occurs in the elderly, par-
ticularly in women [1]. In younger patients, MAC is con-
nected with end-stage renal disease or metabolic disorders 
[2]. MAC has rarely been found in patients with Barlow’s 
disease [3] and Marfan’s syndrome [4].
Caseous calcification of the mitral annulus (CCMA) 
or liquefaction necrosis is a relatively uncommon variant 
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of MAC. Deluca et al. reported the prevalence of CCMA 
in the entire population as 0.068% and 0.64% in patients 
with MAC [1].
The precise mechanism of caseous transformation of 
CCMA is not well understood [1]. Spontaneous resolution 
of CCMA and the transformation back to MAC have been 
reported in the literature [1,2,5].
Typically, CCMA appears as a round mass with an 
echolucent centre made up of a putty-like admixture of 
fatty acids, cholesterol, and calcium, located in the pos-
terior mitral annulus, but it may also involve the entire 
annulus and extend to the mitral apparatus [6]. 
CCMA is mostly benign and incidentally diagnosed; 
however, it may be associated with mitral valvular dys-
function, conduction abnormalities, or systemic emboli-
sation [2,7-9].
Typical location and imaging features of transthoracic 
echocardiogram (TTE) are usually sufficient to confirm 
the diagnosis of CCMA.
However, in some cases the diagnosis of CCMA may 
be challenging and require differentiation from cardiac 
tumours, myocardial abscesses, and other abnormalities 
occurring in the atrioventricular groove. Misdiagnosed 
CCMA leads, in some cases, to unnecessary surgery. 
On the other hand, in relation to the increasing num-
ber of cardiac computed tomography (CT) examinations, 
CCMA may be accidentally discovered during an exam-
ination and the radiologist needs to be familiar with its 
appearance.
The purpose of this study was to assess characteristic 
radiological features of caseous calcification of the mitral 
annulus using multislice computed tomography and to 
compare the usefulness of CT and TTE in the diagnosis 
of CCMA.
Material and methods
In this study, we retrospectively analysed 17 cases of 
CCMA, which were recognised by CT between 2011 and 
2017.
All patients had had a standard transthoracic echo-
cardiography. Two of them had additionally had tran-
soesophageal echocardiography as a routine procedure 
in qualifying for transcatheter aortic valve implantation 
(TAVI). The two-dimensional technique was used to 
demonstrate the localisation and density of the pathologic 
structure. With colour, pulse, and continuous Doppler, we 
searched for accompanying valve diseases.
Computed tomography (CT) examinations were per-
formed with a dual-source scanner (Somatom Flash, Sie-
mens Medical Solutions, Erlangen, Germany) with the 
use of retrospective ECG gating, with beam collimation of 
64 × 0.6 mm, 128 slices, a gantry rotation time of 280 ms, 
and tube voltage 100-120 kV depending on the patient’s 
body mass.
Unenhanced scans and scans after the IV injection of 
contrast medium were obtained. 
Highly iodinated contrast material (≥ 350 mg/ml) 
was administered in the antecubital vein in the amount of 
80-100 ml at a flow rate of 5 ml/s, followed by a 30-ml sa-
line chaser. Image acquisition was initiated 4 s after reach-
ing 100 H.U. threshold enhancement within the region of 
interest placed in the ascending aorta.
The following features of CCMA were evaluated: loca-
tion, size, attenuation, enhancement after contrast admin-
istration, and margins.
Eleven patients (64.7%) were referred for CT with 
a suspicion of cardiac tumours based on TTE results; in 
one patient CCMA diagnosis was established incidental-
ly based on TTE, and CT was performed to confirm the 
diagnosis; in five cases CCMA was detected incidentally 
during coronary CT angiography in patients with a suspi-
cion of coronary artery disease. 
Descriptive statistics was used to provide a summary 
of the data. Frequency and percentages were reported for 
categorical variables; summary statistics, including the 
mean, SD, and range were calculated.
Results
Seventeen patients with CCMA were analysed (15 women 
and two men, with an age range from 52 to 91 years and 
mean age of 72 ± 0.7 years). The clinical characteristics of 
the patients are shown in Table 1.
In all cases, the two-dimensional echocardiography 
visualised an echo-dense structure with an irregular ap-
pearance involving the mitral valve annulus (Figure 1). 
In five (29.4%) cases the acoustic shadowing artefact was 
visible. In four (23.5%) cases the mass contained central 
areas of echolucency with no flow on colour Doppler ex-
amination (Figure 2). In 13 (76.5%) patients a periannu-
lar mass was localised at the posterior annular region of 
the mitral valve, in four (23.5%) patients it involved other 
segments of the mitral annulus – the lateral part or the 
entire ring. In 10 (58.8%) cases, the mass also included 
the mitral leaflet. In one case (5.9%), it extended the mi-
tral apparatus, and in one case (5.9%) the atrioventricular 
groove. Additionally, we found at least moderate valve 
Table 1. Clinical characteristics of patients
N = 17 Percentage
Age (y) (mean ± SD) 72 ± 0.7
Women/men 15/2 88.2/11.8
History
Hypertension 11 64.7
Atrial fibrillation 7 41.2
Coronary heart disease 6 35.3
Diabetes mellitus 5 29.4
Chronic renal failure 1 0.6
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disease in 11 (64.7%) examined patients. Only in one pa-
tient (5.9%%) was CCMA recognised based on TTE and 
confirmed by CT.
On CT CCMA appeared as a round mass in one case, 
in 10 (58.8%) cases as an oval mass, and in six (35.3%) 
patients it had a semilunar shape. In all patients who 
were referred for CT with a suspicion of cardiac tumours, 
CCMA appeared as an oval mass, except for one case 
where it was a round mass. 
In 15 (88.2%) patients, CCMA was located in the poste-
rior mitral annulus; in two cases, CCMA involved the ante-
rior part of the mitral annulus. In 10 cases, CCMA involved 
the base of the posterior leaflet of the mitral valve. In one 
case, it extended to the chordae tendineae, and in one case 
the mass was bulging into the left ventricular cavity. 
In all cases on unenhanced CT, CCMA appeared as 
a hyperdense mass (Figure 3A, 4A). On CT after contrast 
administration in 10 cases, (58.8%) CCMA had a hypo-
dense centre (Figure 3B) and in seven (41.2%) it had a hy-
perdense centre (Figure 4B).
Table 2 shows the locations of CCMA and its appear-
ance on CT and TTE.
The mean attenuation value of the central part of 
CCMA on unenhanced scans was 231.42 ± 175.56 H.U. 
(attenuation value range from 39 H.U. to 512 H.U.), with 
four patients with mean attenuation values below 100 H.U.
The mean attenuation value of the central part of 
CCMA after IV contrast material administration was 
230.23 ± 155.16 H.U. (attenuation value ranged from 
41 H.U. to 544 H.U.). We did not observe significant 
enhancement after IV contrast agent administration. 
A hyperdense rim was observed in all cases with the 
exception of one patient. The mean size of CCMA was 
26 ± 12.51 mm (range from 10 to 64 mm).
Figure 1. Two-dimensional echocardiogram, in the apical 3-chamber view, 
a calcific mass attached to the mitral annulus with acoustic shadowing 
(arrow)
Figure 2. Two-dimensional echocardiogram, in the apical 4-chamber view 
round echo-dense mass with smooth borders situated in the periannular re-
gion, with no acoustic shadowing artefact and central areas of echolucency 
resembling liquefaction (arrow)
Figure 3. Cardiac CT; A) unenhanced CT, B) contrast enhanced CT, 4-chamber views show a round hypodense mass with peripheral linear calcification 
(arrows)
A B
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Table 2. The locations of CCMA and its appearance on CT and TTE
Patient 
number
Sex TTE
localisation
TTE density TTE
valvular disease
CT 
localisation
CT 
density 
1 F Posterior ring Hyperdense with 
hypodense centre
Moderate MR, 
moderate TR
Posterior
ring, attached 
posterior leaflet
Centrally hypodense, 
peripherally 
calcified mass
2 F Posterior ring, 
posterior leaflet
Hyperdense with 
hypodense centre
Mild MR, mild AR Posterior ring, 
posterior leaflet
Hyperdense with 
peripherally calcified 
3 F Posterior ring, 
atrioventricular groove
Hyperdense Mild MR Posterior ring, 
LV myocardium
Hypodense with 
peripherally calcified
4 F Posterior ring Hyperdense,
acoustic shadowing
Moderate MR,
mild AR
Posterior ring, posteriori leaflet, 
LV myocardium
Hyperdense, 
peripherally calcified 
5 F Posterior ring, 
posterior leaflet
Hyperdense Mild MR Posterior ring, 
posterior leaflet
Centrally hyperdense, 
peripherally calcified 
6 F Lateral ring Hyperdense Mild MR, mild AR, 
moderate TR
Posterior ring Hyperdense, 
peripherally calcified
7 M Whole ring Hyperdense with 
acoustic shadowing
Mild MR, severe AS Posterior
ring
Centrally hypodense, 
peripherally calcified
8 F Lateral ring, both leaflets, 
subvalvular apparatus
Hyperdense Mild MR, mild TR Posterior ring posterior leaflet, 
right AV groove 
Hyperdense, partially 
peripherally calcified 
9 F Posterior ring, 
posterior leaflet
Hyperdense Moderate MR,  
mild AI, mild TR
Posterior ring, 
posterior leaflet
Centrally hypodense, 
peripherally calcified 
10 M Posterior ring, 
posterior leaflet
Hyperdense with 
hypodense centre
Moderate MR,  
mild AR, mild TR
Posterior leaflet Centrally hypodense, 
peripherally calcified
11 F Posterior ring, 
posterior leaflet 
Hyperdense Moderate MR Posterior ring, 
posterior leaflet 
Hyperdense, 
peripherally calcified
12 F Posterior ring Hyperdense with 
hypodense centre
Moderate MS,  
mild MR, severe AS
Posterior ring, 
LV myocardium
Hypodense, 
peripherally calcified 
13 F Whole ring,
posterior leaflet
Hyperdense, 
acoustic shadowing
Mild MR, severe AS Whole ring, posterior leaflet, 
anterior ring
Hyperdense, 
peripherally calcified 
14 F Posterior ring Hyperdense Mild MR Posterior ring Hypodense, 
peripherally calcified 
15 F Posterior ring, 
posterior leaflet
Hyperdense, 
acoustic shadowing
Moderate MR, severe 
AS, moderate TR
Posteriori ring, 
posterior leaflet
Hypodense 
16 F Posterior ring, 
posterior leaflet
Hyperdense, 
acoustic shadowing
Mild MR, severe AS Whole ring Hypodense, 
with calcifications 
17 F Posterior ring,
posterior leaflet
Hyperdense Mild MR Posteriori ring 
posteriori leaflet
Hypodense 
with calcification 
AS – aortic stenosis, MR – mitral regurgitation, AI – aortic insufficiency, TR – tricuspid regurgitation 
Figure 4. Cardiac CT; A) unenhanced CT, B) contrast enhanced CT, 4-chamber views show an oval hyperdense mass with calcification (arrows) in the left 
atrioventricular groove
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One patient had had aortic valve replacement due to 
severe aortic stenosis (AS), one had had aortic and mitral 
valve replacement due to severe AS and moderate mitral 
regurgitation (MR), and two had had the TAVI procedure. 
No one was operated on only for CCMA. The diagnosis 
of CCMA was verified histologically in one patient who 
underwent cardiac surgery.
Discussion
Caseous calcification of the mitral annulus is an uncom-
mon variant of mitral annulus calcification (MAC). The 
prevalence of MAC in echocardiographic studies was 
10.6% of the population. Among these cases CCMA was 
found in 0.63% to 0.64%, which means that CCMA is 
found in 0.06-0.07% of the population [1,2]. Deluca found 
14 patients with CCMA among 20.468 consecutive pa-
tients included in the study [1]. The largest reported study 
of CCMA is based on echocardiography and includes 18 
patients with CCMA [10]. The CT and MRI studies are 
solely based on case reports. According to our knowledge, 
we present the largest series of CCMA cases diagnosed 
by CT and echocardiography. In most cases, CCMA is an 
incidental finding during echocardiography, and echocar-
diographic characteristic features are sufficient for proper 
diagnosis. On TTE, CCMA often appears as a round or 
oval, echogenic mass with a central area of echolucency, 
with smooth borders, without acoustic shadowing be-
hind the mass, and it is localised into the posterior mitral 
annulus [10]. The recognition of CCMA by TTE may be 
difficult in patients with limited acoustic viewing, a poor 
quality of echocardiography images, or an atypical ap-
pearance. Such patients require other imaging modalities 
such as MRI or CT. In contrast to other studies, in most of 
our cases the appearance of CCMA in echocardiography 
was not characteristic. In 13 (76.5%) echocardiograms, 
we did not find the typical central area of echolucency 
resembling liquefaction. In five cases (29.4%), the mass 
created an acoustic shadowing, which is a hallmark of 
MAC. Therefore, in the majority of our cases TTE was 
not sufficient to confirm the diagnosis, and we considered 
CT as a second diagnostic tool. 
On unenhanced CT, CCMA appears as a hyperdense 
oval or crescent-shaped mass with a calcified rim, located 
in the posterior ring of the mitral valve. In some cases, it 
extends over the anterior ring and into the left ventricular 
myocardium, mostly attached to the posterior leaflet of the 
mitral valve. After contrast administration, CCMA appears 
as a hypo-, iso-, or hyperdense mass without enhancement. 
CT features of CCMA, especially unenhanced images, 
are characteristic and CT imaging can lead to a defini-
tive diagnosis. Cardiac MR is considered the technique 
of choice in the diagnosis of CCMA. However, access to 
cardiac MR may be limited and CT is a widely available 
method and seems to be sufficient to recognise CCMA. 
CCMA may sometimes be associated with mitral 
valve dysfunction. Most often it causes mitral regurgita-
tion and is less likely to cause mitral stenosis [11]. The 
extension of CCMA in the mitral ring involving mitral 
leaflets may be precisely assessed by CT, but assessment 
of the mitral valve function is limited on CT. TTE is the 
method of choice in the assessment of valvular function. 
In our study, we found at least moderate valvular heart 
disease in 11 (65%) patients. The most frequent was mitral 
regurgitation. Severe valvular dysfunction is the current 
indication for surgical intervention.
CCMA is mostly a benign finding, but it may be a po-
tentially serious condition causing cerebral stroke. Several 
studies reported a connection between mitral annular cal-
cification and stroke [8,12,13]. The mechanism of stroke 
is unclear. Embolisation of small, calcified parts and 
thrombus formations of CCMA are considered as possible 
causes of stroke [12]. The size, mobility, and location of 
CCMA may be factors increasing the incidence of cerebral 
stroke [12]. In our study, in one patient an embolism of 
the retinal artery was associated with CCMA.
Computed tomography allows for a precise descrip-
tion of the size, location, and extent of calcifications of 
CCMA; TTE allows for better visualisation of CCMA 
mobility. 
In some cases, mitral annular calcification requires 
differentiation with caseous calcifications. MAC is usual-
ly seen as a C-, J-, U-, or O-shape around the mitral valve 
with coarse structure and hyperdense attenuation, and it 
seldom mimics a mass [14]. The appearance of CCMA is 
focal with an ovoid mass-like with more homogeneous 
attenuation than MAC [15]. “Bone windows” of CT al-
low better recognition of the caseous nature of MAC [15]. 
Some authors report misdiagnoses of CCMA as cardiac 
tumours and abscesses if the diagnosis is based only on 
echocardiography [10]. CCMA requires differentiation 
from infected mitral calcification, calcified tumours, a di-
lated coronary sinus, a large aneurysm of the circumflex 
coronary artery, and enlarged lymph nodes [1,16,17].
Misdiagnosis of CCMA as a tumour, abscess, or aneu-
rysm may result in unnecessary exploratory cardiotomy.
The clinical context is essential for establishing the 
correct diagnosis.
In our study, 11 patients were referred for CT exami-
nation with a suspicion of cardiac tumour by TTE. CCMA 
requires differentiation from other left atrial masses such 
as myxoma, haemangioma, and leiomyosarcoma [2]. Hy-
perattenuation on unenhanced CT without enhancement, 
after contrast administration, is typical of CCMA and al-
lows for easy differentiation from other cardiac masses. 
Currently, conservative medical management is suggested 
for CCMA without severe mitral valve dysfunctions [18]. 
Caseous mitral annular calcification may create a diagnos-
tic dilemma, but knowledge about characteristic imaging 
features leads to a correct diagnosis. 
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The limitation of this work is the small group of 
CCMA patients. However, the study is one of the largest 
in the literature.
Conclusions
In cases of the atypical appearance of CCMA on TTE, CT 
can lead to a definitive diagnosis. 
The combination of unenhanced CT and after IV 
contrast administration scans allows for recognition and 
distinction of CCMA from other pathologies, while TTE 
allows for assessment of additional valve dysfunction. 
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